Immuno-Biological Laboratories (4570) · InitiativeRestated
Development of antibodies and assay systems for HTLV-1-related proteins
First written in FY2018-Q1. 1 of 2 entries say "Restated". Latest entry: FY2020.
2entries
4years
0from disclosures
How it moved
Same theme, other companies
Development of research reagents comprising HTLV-1- and ATL-related antibodies and assay systemsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2020RestatedAnnual report
「Through joint research with a university, we are developing antibodies and an assay system for proteins considered potentially useful in diagnosing human adult T-cell leukemia (ATL).」
Development of antibodies and an assay system related to HTLV-1 and ATL continues. - FY2018-Q1First statedAnnual report
「We are developing antibodies and an assay system for proteins associated with cells infected by HTLV-1, the virus that causes adult T-cell leukemia (ATL), and plan to begin selling them first as research reagents.」
For the first time, the filing states a plan to develop antibodies and an assay system for proteins associated with HTLV-1-infected cells and initially sell them as research reagents.